Please login to the form below

Not currently logged in
Email:
Password:

Pfizer extends offer to acquire King

Parker Tennessee Corp, a wholly-owned subsidiary of Pfizer, has extended the expiration date of its tender offer for all shares of King Pharmaceuticals to December 17, 2010
Parker Tennessee Corp, a wholly-owned subsidiary of Pfizer, has extended the expiration date of its tender offer for all shares of King Pharmaceuticals to December 17, 2010. The tender offer, of $14.25 per share, was previously due to expire on November 19, 2010. Other terms and conditions of the offer remain unchanged. 

The $3.6bn acquisition was first announced in October 2010. The tender offer is being extended because certain conditions to the tender offer are not yet satisfied, including the expiration or earlier termination of any waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and applicable foreign antitrust or competition laws. However, the companies are still on track to achieve their aim to close the acquisition by at latest the end of the first quarter of 2011, assuming they receive the appropriate regulatory clearances. 

To date, Pfizer has acquired almost three quarters (74.9 per cent) of the outstanding shares of King’s common stock. 

22nd November 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics